Aug 6, 2026 07:30AM
Aug 6, 2026 07:30AM
May 27, 2026 08:00AM
May 26, 2026 08:01AM
May 26, 2026 08:00AM
May 18, 2026 08:01AM
May 18, 2026 08:00AM BioVie Announces Completion of Phase 2 SUNRISE-PD Trial in Early-Stage Parkinson’s Disease
Apr 27, 2026 08:00AM
Apr 27, 2026 08:00AM
Feb 23, 2026 08:00AM
Nov 19, 2025 08:00AM
Sep 26, 2025 08:00AM
Aug 13, 2025 04:05PM
Aug 13, 2025 04:05PM BioVie Highlighted ADDRESS-LC Phase 2 Trial Design Exploring Bezisterim for the Treatment of Neurological Symptoms of Long COVID at Keystone Symposia on Long COVID and Other Post-Acute Infection Syndr
Aug 11, 2025 04:05PM
Aug 11, 2025 04:05PM
Aug 7, 2025 08:43PM
Aug 7, 2025 08:43PM
Jul 24, 2025 08:01AM
Jul 24, 2025 08:00AM
Jul 22, 2025 09:05AM BioVie names Amy Chappell and Kameel Farag to board of directors
Jul 22, 2025 08:00AM
Jul 9, 2025 08:00AM
Jun 26, 2025 08:00AM
Jun 24, 2025 04:05PM
May 15, 2025 08:00AM
May 14, 2025 07:30AM
May 7, 2025 08:00AM BioVie to Present Rationale and Design of Phase 2 SUNRISE-PD Clinical Trial at the 30th World Congress on Parkinson’s Disease and Related Disorders (IAPRD 2025)
May 5, 2025 08:02AM
May 5, 2025 08:00AM
Apr 16, 2025 08:00AM
Mar 27, 2025 08:00AM
Nov 20, 2024 08:00AM
Nov 4, 2024 08:00AM
Oct 29, 2024 04:05PM BioVie Inc. Announces Closing of Registered Direct Offering
Oct 28, 2024 04:10PM
Oct 28, 2024 04:10PM
Oct 28, 2024 03:15PM
Oct 28, 2024 03:13PM
Oct 24, 2024 04:10PM
Oct 23, 2024 03:25PM
Oct 23, 2024 03:24PM BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
Oct 23, 2024 08:00AM
Oct 22, 2024 04:01PM
Oct 21, 2024 03:08PM
Oct 21, 2024 03:08PM
Oct 15, 2024 08:06AM
Oct 15, 2024 08:00AM
Oct 1, 2024 08:05AM BioVie Inc. (BIVI) Receives Notice of Allowance for United States Patent Application Covering Novel Liquid Formulation of Terlipressin
Oct 1, 2024 08:00AM

450,434 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All